• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis.

Pfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective
HealthPfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective
By Robert Langreth and BloombergNovember 18, 2020
Moderna says its COVID-19 vaccine is 94.5% effective
HealthModerna says its COVID-19 vaccine is 94.5% effective
By Robert Langreth and BloombergNovember 16, 2020
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
HealthModerna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
By Robert Langreth and BloombergNovember 12, 2020
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
HealthPfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By Robert Langreth, Naomi Kresge, Riley Griffin and BloombergNovember 9, 2020
Gilead shares jump on FDA approval of remdesivir
HealthGilead shares jump on FDA approval of remdesivir
By Robert Langreth and BloombergOctober 23, 2020
BRAZIL-HEALTH-VIRUS-VACCINE
AstraZeneca COVID-19 vaccine enters final-stage trial in the U.S.
By Robert Langreth and BloombergAugust 31, 2020
Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida
HealthTrump administration strikes another deal for a promising COVID-19 vaccine
By Olivia Raimonde, Robert Langreth and BloombergAugust 11, 2020
BRAZIL-CHINA-HEALTH-VIRUS-VACCINE-TRIAL
HealthExperts share a clearer timeline of when most Americans will get COVID-19 vaccine
By Anna Edney, Josh Wingrove, Robert Langreth and BloombergAugust 11, 2020
Gilead coronavirus treatment drug Remdesivir
HealthGilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By Robert Langreth and BloombergJune 29, 2020
Coronavirus test used at White House faces accuracy questions
HealthHow accurate are the coronavirus tests used by the White House? A new report is raising questions
By Michelle Fay Cortez, Robert Langreth, Kristen V. Brown and BloombergMay 13, 2020
Gilead remdesivir price
FinanceGilead shares tumble on reports that the Chinese trial of its coronavirus drug was not successful
By Drew Armstrong, Robert Langreth and BloombergApril 23, 2020
Young people are getting sick from coronavirus.
HealthYoung people are getting extremely sick from coronavirus, according to new evidence
By Michelle Cortez, Angelica LaVito, Robert Langreth and BloombergMarch 18, 2020
An emergency worker in protective clothing drives an ambulance carrying a person diagnosed with Covid-19 from the Diamond Princess cruise ship, on Feb. 13, 2020 in Yokohama, Japan.
Health‘Tip of the iceberg:’ Why Covid-19 deaths will keep rising even as the coronavirus outbreak wanes
By Robert Langreth, Michelle Fay Cortez and BloombergFebruary 13, 2020
No guns sign
RetailWalgreens Joins Walmart and Kroger in Saying Open-Carry Firearms Are Not Welcome in Stores
By Polly Mosendz, Robert Langreth and BloombergSeptember 5, 2019
Rite Aid Pharmacy
LeadershipRite-Aid Pharmacy Chain Tries to Heal Itself: C-Suite Execs Are Out, 400 Jobs Will Be Cut
By Robert Langreth and BloombergMarch 12, 2019
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Personal Finance
Current price of oil as of June 23, 2026placeholder alt text
By Joseph HostetlerJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.